SEC 13F Intelligence

Managers / Q2 2024 · view latest →

Sonic GP LLC

CIK 0001964290 · 400 HOBRON LANE, SUITE 3709, HONOLULU, HI, 96815 · 8086493381

Reported Value
$48M
Q2 2024
Positions
15
Filings on Record
9
2019–present window
Filed
Aug 14, 2024
original filing

Summary

Sonic GP LLC reported $48M in U.S.-listed holdings across 15 positions for Q2 2024.

The portfolio is heavily concentrated: FENC alone accounts for 30.4% of reported value.

Compared with Q1 2024, the fund opened 1 new position and exited 1.

Portfolio Metrics

Turnover
+3.9%
vs prior filed quarter
Top-10 Concentration
+95.4%
share of reported value
Largest Position
+30.4%
Fennec Pharmaceuticals
New / Exited
1 / 1
positions this quarter

Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded, with multiple share classes and repeated sub-manager rows for the same issuer combined into one position — the same rule the holdings table uses by default. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.

Reported Value by Quarter

13F Reported Value
Q4 ’22: $133MQ4 ’22Q1 ’23: $131MQ2 ’23: $150MQ2 ’23Q3 ’23: $103MQ4 ’23: $87MQ4 ’23Q1 ’24: $76MQ2 ’24: $48MQ2 ’24Q3 ’24: $44MQ4 ’24: $45MQ4 ’24filingsflow.com

Portfolio Composition

By security type
Common Stock: 91.7%Other: 7.7%Equity WRT: 0.5%
  • Common Stock · 91.7% · $44M
  • Other · 7.7% · $4M
  • Equity WRT · 0.5% · $251,996

Quarter-over-Quarter Changes full breakdown →

vs Q1 2024 (amended baseline)

IssuerMoveShare ΔShares nowValue ΔValue now
PARAMOUNT GLOBALNEW+200.0K200.0K+$2M$2M
VIRTVIRTU FINL INCSOLD OUT100.0K0$2M$0
CEDAR FAIR L PTRIMMED70.0K50.0K$2M$3M
UALUNITED AIRLS HLDGS INCTRIMMED60.0K111.8K$3M$5M
PRKSUNITED PARKS & RESORTS INCTRIMMED14.7K39.6K$898,902$2M
CCITIGROUP INCTRIMMED20.0K80.7K$1M$5M
RGNXREGENXBIO INCTRIMMED90.0K453.1K$6M$5M
FENCFENNEC PHARMACEUTICALS INCHELD+02.41M$12M$15M

Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.

Holdings — Q2 2024

14 positions
#IssuerClass% PortfolioValueShares
1FENCFENNEC PHARMACEUTICALS INChistory →COM30.37%$15M2.41M
2UALUNITED AIRLS HLDGS INChistory →COM11.23%$5M111.8K
3RGNXREGENXBIO INChistory →COM10.94%$5M453.1K
4CCITIGROUP INChistory →COM NEW10.58%$5M80.7K
5BHFBRIGHTHOUSE FINL INChistory →COM8.95%$4M100.0K
6ASTLALGOMA STL GROUP INCCOM · *W EXP 10/19/2026.27%$3M680.0K
7CEDAR FAIR L PDEPOSITRY UNIT5.61%$3M50.0K
8PRKSUNITED PARKS & RESORTS INChistory →COM4.44%$2M39.6K
9PARAMOUNT GLOBALCLASS B COM4.29%$2M200.0K
10AUIDAUTHID INChistory →COM2.68%$1M125.0K
11TROXTRONOX HOLDINGS PLChistory →SHS2.04%$989,33363.1K
12MURAL ONCOLOGY PUB LTD COORD SHS1.08%$524,330167.0K
13REE AUTOMOTIVE LTDSHS CL A NEW1.06%$511,846130.7K
14QUREUNIQURE NVSHS0.46%$224,00050.0K

Filing History

QuarterReported ValuePositionsFiledTypeLinks
Q4 2024$45M15Feb 14, 202513F-HRchanges · EDGAR ↗
Q3 2024$44M15Nov 14, 202413F-HRchanges · EDGAR ↗
Q2 2024$48M15Aug 14, 202413F-HRchanges · EDGAR ↗
Q1 2024$76M15May 15, 202413F-HRchanges · EDGAR ↗
Q4 2023$87M16Feb 14, 202413F-HRchanges · EDGAR ↗
Q3 2023$103M23Nov 14, 202313F-HRchanges · EDGAR ↗
Q2 2023$150M24Aug 14, 202313F-HRchanges · EDGAR ↗
Q1 2023$131M25May 15, 202313F-HRchanges · EDGAR ↗
Q4 2022$133M25Feb 14, 202313F-HRchanges · EDGAR ↗

13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.